Genome Institute of Singapore-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Genome Institute of Singapore - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013392
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:シンガポール
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Genome Institute of Singapore (GIS) is a research institute that provides various research programs and services in different areas. The institute concentrates on genomic sciences to improve public health and prosperity in Singapore. It handles the latest in technology and comprises early career researchers such as next generation sequencing, high-throughput biology, genome engineering, genotyping, cytogenetics and single cell genomics, among others. GIS performs research in human genomics, cancer genomics, infectious diseases, genomics technologies, cancer stem cell biology, tissue regeneration and computational biology areas, among others. The institute offers its services to PhD, MD and M.B.B.S. graduates through its GIS Fellow Programs, to carry their research projects. GIS is headquartered in Singapore.

Genome Institute of Singapore – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Genome Institute of Singapore, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Genome Institute of Singapore, Medical Devices Deals, 2011 to YTD 2017 9
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Atreca Enters into Agreement with Genome Institute of Singapore 11
InvitroCue Enters into Research Agreement with Genome Institute of Singapore 12
PerkinElmer Forms Joint Venture with Genome Institute of Singapore 13
Genome Institute of Singapore Extends Research Agreement with Pacific Biosciences 14
Genome Institute of Singapore Enters Into Agreement With Oxford Biodynamics For Stem Cell Epigenetic Signatures 15
Genome Institue of Singapore Partners With Fluidigm To Establish Single-Cell Genomics Research Center 16
Appistry Enters Into Co-Development Agreement With Genome Institute of Singapore 17
Genome Institute of Singapore – Key Competitors 18
Genome Institute of Singapore – Key Employees 19
Genome Institute of Singapore – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Joint Venture 20
Recent Developments 21
Strategy And Business Planning 21
Jul 24, 2017: Launch of New Joint Innovation Laboratory to Advance Personalised Medicine for Cancer Treatment 21
Government and Public Interest 22
Jul 29, 2016: Singapore Scientists Grow Mini Human Brains 22
Jul 18, 2016: Singapore scientists discover new pathways leading to cancer progression 24
Jun 23, 2016: Scientists discover unsuspected bacterial link to bile duct cancer 26
Jun 03, 2016: Novel study on histones provides better understanding of gene regulation 27
Apr 11, 2016: Discovered Genes Reveal Novel Insights into Biology of Glaucoma 28
Product News 29
May 13, 2016: New technique paves the way for drug targeting to fight microbial resistance 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Key Facts 2
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Genome Institute of Singapore, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Genome Institute of Singapore, Deals By Therapy Area, 2011 to YTD 2017 8
Genome Institute of Singapore, Medical Devices Deals, 2011 to YTD 2017 9
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Atreca Enters into Agreement with Genome Institute of Singapore 11
InvitroCue Enters into Research Agreement with Genome Institute of Singapore 12
PerkinElmer Forms Joint Venture with Genome Institute of Singapore 13
Genome Institute of Singapore Extends Research Agreement with Pacific Biosciences 14
Genome Institute of Singapore Enters Into Agreement With Oxford Biodynamics For Stem Cell Epigenetic Signatures 15
Genome Institue of Singapore Partners With Fluidigm To Establish Single-Cell Genomics Research Center 16
Appistry Enters Into Co-Development Agreement With Genome Institute of Singapore 17
Genome Institute of Singapore, Key Competitors 18
Genome Institute of Singapore, Key Employees 19
Genome Institute of Singapore, Joint Venture 20

★海外企業調査レポート[Genome Institute of Singapore-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ethicon US LLC:製品パイプライン分析
    Summary Ethicon US LLC (Ethicon), a subsidiary of Johnson and Johnson, is a medical equipment company which operates through Ethicon Inc, and Ethicon Endo-Surgery Inc. It develops and markets surgical instruments and devices. Its major products include staplers, energy devices, clip appliers, trocar …
  • Tompkins Financial Corp (TMP)
    Tompkins Financial Corp (TMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Pantheon Resources plc (PANR):企業の財務・戦略的SWOT分析
    Summary Pantheon Resources Plc (Pantheon Resources) is an oil and gas exploration and production company. It explores, develops and produces crude oil and natural gas resource properties. The company invests in oil and gas exploration and development. It operates hydrocarbon producing basins onshore …
  • Sierra Nevada Corporation:企業の戦略・SWOT・財務情報
    Sierra Nevada Corporation - Strategy, SWOT and Corporate Finance Report Summary Sierra Nevada Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Intrasense SA (ALINS):医療機器:M&Aディール及び事業提携情報
    Summary Intrasense SA (Intrasense) is a healthcare technology company that offers software solution for analysis and visualisation of medical images. The company provides a range of clinical apps such as lesion tracking solution, analysis tools, virtual colonoscopy, and lung nodule follow-up softwar …
  • Assam Company India Ltd (ASSAMCO):企業の財務・戦略的SWOT分析
    Assam Company India Ltd (ASSAMCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Kawasaki Heavy Industries Ltd (7012):企業の財務・戦略的SWOT分析
    Kawasaki Heavy Industries Ltd (7012) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • PT Tempo Scan Pacific Tbk (TSPC):企業の財務・戦略的SWOT分析
    PT Tempo Scan Pacific Tbk (TSPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Worldpay Us Inc
    Worldpay Us Inc - Strategy, SWOT and Corporate Finance Report Summary Worldpay Us Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Ramky Infrastructure Limited:企業の戦略・SWOT・財務情報
    Ramky Infrastructure Limited - Strategy, SWOT and Corporate Finance Report Summary Ramky Infrastructure Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Barnes & Noble, Inc.:企業の戦略・SWOT・財務情報
    Barnes & Noble, Inc. - Strategy, SWOT and Corporate Finance Report Summary Barnes & Noble, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Yissum Research Development Company of the Hebrew University of Jerusalem Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Yissum Research Development Company of the Hebrew University of Jerusalem Ltd (YRDC), a subsidiary of Hebrew University of Jerusalem, is a technology transfer company. The company offers marketing and licensing the inventions, products, and technologies developed by the university's faculty, …
  • Touchstone Innovations plc (IVO):企業の財務・戦略的SWOT分析
    Summary Touchstone Innovations Plc (Touchstone Innovations), formerly Imperial Innovations Group Plc, a subsidiary of IP Group Plc, is a technology commercialization and investment company. The company creates, builds, and invests in early-stage pioneering technology companies and licensing opportun …
  • Olink Proteomics AB:企業の製品パイプライン分析
    Summary Olink Proteomics AB (Olink) is a biotechnology company that offers products and services for human protein biomarker research. The company provides portfolio of products such as biomarkers, cardiovascular diseases panels, neurological disease panels, inflammation panels and oncology panels. …
  • SVB Financial Group:企業のM&A・事業提携・投資動向
    SVB Financial Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SVB Financial Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Natera Inc (NTRA):企業の製品パイプライン分析2018
    Summary Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as panorama prenatal testing, pre-implantation genetic testing, miscarriage testing, g …
  • SPR Therapeutics LLC:医療機器:M&Aディール及び事業提携情報
    Summary SPR Therapeutics LLC (SPR Therapeutics) is a medical device company that develops and commercializes neurostimulation products. The company develops therapies for post-surgical pain, neuropathic pain, and musculoskeletal pain. It offers percutaneous peripheral nerve stimulation system for in …
  • 3-D Matrix Ltd (7777):医療機器:M&Aディール及び事業提携情報
    Summary 3-D Matrix Ltd (3-D Matrix) is a regenerative medicine company that focuses at commercializing its self-assembling peptide technology. It develops medical products by applying this technology under a license granted by Massachusetts Institute of Technology (MIT). The technology finds applica …
  • Bruker Corporation:企業のM&A・事業提携・投資動向
    Bruker Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bruker Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • U-Haul International Inc:企業の戦略的SWOT分析
    U-Haul International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆